Ginna Laport

Division of Bone Marrow Transplantation, Stanford University Medical Center, United States of America

Ginna G. Laport, MD

Academic positions:
- Assistant Professor, Division of Blood and Marrow Transplantation

All industry positions (in last five years):

Research interests:
Haploidentical transplantation, adoptive immnotherapy, follicular lymphoma, supportive care

Any other information:

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Hematology > Hematologic Transplantation & Transfusion (since 14 November 2005)

Links

http://bmt.stanford.edu/

All recent recommendations

• 3.0
  Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor.
  Recommended by Ginna Laport
  
• 6.0
  Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.
  Recommended by Ginna Laport
  
• 4.9
  In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
  Recommended by Ginna Laport, Sebastian Giebel, Riccado Varaldo
  
• 6.0
  Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
  Recommended by Ginna Laport
  
• 3.0
  Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
  Recommended by Ginna Laport
  
• 3.0
  Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
  Recommended by Ginna Laport